Not just a nursing home problem: Antipsychotic use increasing in elderly, community-dwelling dementia...
By
Kimberly Marselas
Apr 24, 2018
While regulatory focus has pushed the use of antipsychotics lower in skilled nursing facilities recently, off-label use is rising among dementia patients living in assisted living and other community settings.
Physician defends use of antipsychotics for dementia patients in nursing homes
Jun 02, 2011
In response to a recent report from the Office of the Inspector General, a prominent psychiatrist is defending the practice of prescribing antipsychotic medications for nursing home residents with dementia.
AstraZeneca settles for $520 million following investigation into improper marketing of anti-psychotic...
Apr 28, 2010
Pharmaceutical giant AstraZeneca has agreed to pay $520 million to end a federal investigation into its alleged illegal marketing of the drug Seroquel for off-label uses, according to reports from Washington.
Many doctors unknowingly prescribe drugs ‘off-label,’ study finds
Aug 26, 2009
A large number of physicians don’t know when they are prescribing drugs, including antipsychotics, “off-label,” according to a recent report.
